Specify a stock or a cryptocurrency in the search bar to get a summary
Sawai Group Holdings Co Ltd
4887Sawai Group Holdings Co., Ltd., together with subsidiaries, engages in the research and development, manufacturing, and marketing of generic pharmaceuticals. The company offers generic drugs in various dosage forms, including tablets, oral dispersing tablets, capsules, granules, injectables, tapes, ophthalmic or nasal solutions, syrups, and other forms for various therapeutic areas comprising cardiovascular, gastro-intestinal, blood/body fluid, other metabolic, antibiotics, central nervous system, antiallergics, anti-cancer, urogenital organs and anus, chemotherapeutic and antineoplastic agents, respiratory system, etc., as well as vitamin preparations. It sells its generic drugs through distributors, wholesalers, and retailers in Japan and the United States. Sawai Group Holdings Co., Ltd. was founded in 1929 and is headquartered in Osaka, Japan. Address: 5-2-30, Miyahara, Osaka, Japan, 532-0003
Analytics
WallStreet Target Price
367 610.63 JPYP/E ratio
20.2143Dividend Yield
2.66 %Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 4887
Dividend Analytics 4887
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
18 %Dividend History 4887
Stock Valuation 4887
Financials 4887
Results | 2019 | Dynamics |